Related Experiment Video
Updated: Aug 24, 2025

06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.3K
[Mechanical circulatory support in refractory cardiogenic shock: retrospective register study]
P P Savvinova1,2, V N Manchurov1,2, B L Haes2
1Yevdokimov Moscow State University of Medicine and Dentistry.
Terapevticheskii Arkhiv
|October 26, 2022
Summary
Mechanical circulatory support (MCS) significantly reduces mortality in acute myocardial infarction (AMI) patients with cardiogenic shock (CS). VA-ECMO showed particular effectiveness, suggesting its consideration for improved outcomes in these critical cases.
Area of Science:
- Cardiology
- Critical Care Medicine
- Medical Devices
Context:
- Cardiogenic shock (CS) is a major cause of mortality in acute myocardial infarction (AMI).
- Despite advancements, mortality rates for CS remain high.
- Mechanical circulatory support (MCS) offers a promising therapeutic avenue.
Purpose:
- To evaluate the effectiveness and safety of MCS in patients diagnosed with AMI and CS.
- To compare outcomes between patients receiving MCS and those not receiving it.
Summary:
- A study of 47 patients with AMI and refractory CS revealed significantly lower mortality in those treated with MCS (59%) compared to those without (93%).
- Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) demonstrated a significant impact on reducing mortality (p=0.02), whereas intra-aortic balloon pump (IABP) did not show statistical significance (p=0.16).
Impact:
- VA-ECMO is associated with reduced mortality in AMI patients experiencing refractory CS.
- Findings suggest VA-ECMO should be strongly considered for managing refractory CS in AMI.
- Further research is warranted to determine the optimal MCS strategy for CS patients.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
19
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Cardiopulmonary Resuscitation IV: Pharmacological Management
65
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
65

